InterGenetics announced FetalSafe®, a new genetic test designed and implemented for the first time, that detects easily and safely hundreds of different serious genetic diseases which may affect the newborn child. The scientific team is headed by Professor C. Pangalos and Dr. C. Konialis, who designed this new extended prenatal test.
This test is based upon sophisticated analysis methods of the fetal genome, obtained safely either in the 1st trimester by chorionic villi sampling (CVS) or in the 2nd trimester through amniocentesis. This is a diagnostic test and the results are available in only 7 days, in contrast to other prenatal tests which are based on statistical risk calculations and are not diagnostic.